View in EDS

MAGE-A3 as a target for cancer immunotherapy: A systematic review of clinical and preclinical evidence.

Saved in:
Bibliographic Details
Title: MAGE-A3 as a target for cancer immunotherapy: A systematic review of clinical and preclinical evidence.
Authors: Telang G; Amity Institute of Biotechnology, Amity University Mumbai, Maharashtra, India. Electronic address: gaurangtelang98@gmail.com., Mishra S; Amity Institute of Biotechnology, Amity University Mumbai, Maharashtra, India. Electronic address: smritimishra44@gmail.com., Sureshbabu A; School of Bioengineering, Bharath Institute of Higher Education and Research, Chennai, Tamil Nadu 600073, India. Electronic address: anuragsureshbabu@gmail.com., Kulkarni S; Amity Institute of Biotechnology, Amity University Mumbai, Maharashtra, India. Electronic address: samkul1823@gmail.com., Joshi S; Acuere Biosciences Pvt. Ltd., Pune, Maharashtra 411043, India. Electronic address: drjoshisr@gmail.com., Singh R; Amity Institute of Biotechnology, Amity University Mumbai, Maharashtra, India. Electronic address: rsingh1@mum.amity.edu.
Source: Current problems in cancer [Curr Probl Cancer] 2025 Oct; Vol. 58, pp. 101237. Date of Electronic Publication: 2025 Jul 30.
Publication Type: Journal Article; Systematic Review
Journal Info: Publisher: Mosby Country of Publication: United States NLM ID: 7702986 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-6345 (Electronic) Linking ISSN: 01470272 NLM ISO Abbreviation: Curr Probl Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40743771
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: MAGE-A3 as a target for cancer immunotherapy: A systematic review of clinical and preclinical evidence.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Telang+G%22">Telang G</searchLink>; Amity Institute of Biotechnology, Amity University Mumbai, Maharashtra, India. Electronic address: gaurangtelang98@gmail.com.<br /><searchLink fieldCode="AU" term="%22Mishra+S%22">Mishra S</searchLink>; Amity Institute of Biotechnology, Amity University Mumbai, Maharashtra, India. Electronic address: smritimishra44@gmail.com.<br /><searchLink fieldCode="AU" term="%22Sureshbabu+A%22">Sureshbabu A</searchLink>; School of Bioengineering, Bharath Institute of Higher Education and Research, Chennai, Tamil Nadu 600073, India. Electronic address: anuragsureshbabu@gmail.com.<br /><searchLink fieldCode="AU" term="%22Kulkarni+S%22">Kulkarni S</searchLink>; Amity Institute of Biotechnology, Amity University Mumbai, Maharashtra, India. Electronic address: samkul1823@gmail.com.<br /><searchLink fieldCode="AU" term="%22Joshi+S%22">Joshi S</searchLink>; Acuere Biosciences Pvt. Ltd., Pune, Maharashtra 411043, India. Electronic address: drjoshisr@gmail.com.<br /><searchLink fieldCode="AU" term="%22Singh+R%22">Singh R</searchLink>; Amity Institute of Biotechnology, Amity University Mumbai, Maharashtra, India. Electronic address: rsingh1@mum.amity.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227702986%22">Current problems in cancer</searchLink> [Curr Probl Cancer] 2025 Oct; Vol. 58, pp. 101237. <i>Date of Electronic Publication: </i>2025 Jul 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Systematic Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Mosby%22">Mosby </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7702986 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1535-6345 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201470272%22">01470272 </searchLink><i>NLM ISO Abbreviation: </i>Curr Probl Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40743771
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.currproblcancer.2025.101237
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 101237
    Titles:
      – TitleFull: MAGE-A3 as a target for cancer immunotherapy: A systematic review of clinical and preclinical evidence.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Telang G
      – PersonEntity:
          Name:
            NameFull: Mishra S
      – PersonEntity:
          Name:
            NameFull: Sureshbabu A
      – PersonEntity:
          Name:
            NameFull: Kulkarni S
      – PersonEntity:
          Name:
            NameFull: Joshi S
      – PersonEntity:
          Name:
            NameFull: Singh R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2025 Oct
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1535-6345
          Numbering:
            – Type: volume
              Value: 58
          Titles:
            – TitleFull: Current problems in cancer
              Type: main
ResultId 1